Identifying Clinical Pharmacogenomic Predictors for Antibiotic-associated Severe Cutaneous Adverse Drug Reactions
An International Cohort Pilot Study – BC Children’s Hospital Research Institute Evidence to Innovation Theme Seed Grant Award (2020 – 2021)
Severe Cutaneous Adverse Drug Reactions (SCAR) 2019 International Meeting
From Science to Translation – CIHR Planning and Dissemination Grant (2018 – 2019)
Genomic and Outcomes Databank for Pharmacogenomic and Implementation Studies (GO PGx) – Genome Canada, Genome BC, CIHR Large Scale Applied Research Project Competition
Genomics and Precision Medicine (2018 – 2022)
DSEN SEARCH & PREVENT - Active Surveillance and Evaluation of Adverse Reactions in Canadian Healthcare AND Pharmacogenomics of Adverse Reactions EVEnts Nation-wide Team (Renewal) – CIHR Drug Safety and Effectiveness Network (2014 – 2021)
Domperidone to stimulate milk production during lactation and potential risk of serious ventricular arrhythmia and/or sudden cardiac death – CIHR Drug Safety and Effectiveness Network (2018 – 2020)
Integrating pediatric pharmacogenomic testing into the Canadian health care system – Genome Canada Applications Partnership Program (2017 – 2020)
Assessing the Impact of Pharmacogenomic Testing in Pediatric Oncology – Child and Family Research Institute – Evidence to Innovation Seed Grant Funding (2015 – 2016)
Active surveillance for evaluation of harm of direct acting oral anticoagulants (DOACs) in real world patients – CIHR Drug Safety and Effectiveness Network (2015 – 2017)
Clinical and pharmacogenomic predictors of inter-patient variation in direct acting oral anticoagulant (DOAC) plasma concentrations in real-world patients – CHIR Drug Safety and Effectiveness Network (2015 – 2017)
The Drug Safety and Effectiveness Cross-Disciplinary Training (DSECT) program – CIHR Drug Safety and Effectiveness Network Training Grant (2015 – 2020)
Optimizing Chronic Hepatitis C Treatment Using Pharmacogenomic Biomarkers – CIHR Drug Safety and Effectiveness Network (2014 – 2015)
5-HT3 Antagonists (Antiemetics) & Cardiac Safety, Using an Active Surveillance Approach – CIHR Drug Safety and Effectiveness Network (2013 – 2015)
Implementation of A Pharmacogenetic ADR Prevention Program in BC – Genome British Columbia & BC Provincial Health Services Authority (2012 – 2015)
2019 Fellow of the American College of Clinical Pharmacology (ACCP)
2018 Fellow of the International Society for Pharmacoepidemiology (ISPE)
2016 Canadian Society of Pharmacology and Therapeutics (CSPT) Distinguished Service and Education Award
“Recognizing Leadership Excellence” Award for service as Chair, Data Stewardship Committee at the BC Ministry of Health from 2009 – 2014
Every day, our researchers work towards breakthroughs to transform the lives of kids in BC and around the world. Learn about our latest innovations and advancements in child health.
For the past 20 years, the Canadian Pharmacogenomics Network for Drug Safety (CPNDS) has been working to identify why patients have different responses to drug treatments. As part of a recent $200 million Genome Canada initiative, Dr. Bruce Carleton will be leading a new $17 million project to expand on the work of the CPNDS to make medications safer for…
More than half of all children receive at least one prescription medication a year. Despite this, few drugs have pediatric formulations. In North America and Europe, more than 75 per cent of pediatric prescriptions are considered off-label, meaning children are being prescribed medications that were never studied in their age group. Off-label use is associated…
For the first time ever, BC Children’s Hospital Research Institute has produced a mini Year in Review to publicly share a snapshot of research accomplished during the past fiscal year.
At BC Children’s, we are making discoveries that save lives and transform health care for children in our province and around the world. Our research portfolio includes basic, clinical, population, and public health research.
EXPLORE OUR RESEARCH
Sign up for compelling stories about innovative science, the doctors and researchers who turn ideas into discoveries and treatments, and the kids and families whose lives are changed.
BC Children's Hospital Research Institute operates on the ancestral and unceded territory of the Coast Salish peoples — xʷməθkʷəy̓əm (Musqueam), Sḵwx̱wú7mesh (Squamish), and Səl̓ílwətaʔ/Selilwitulh (Tsleil-Waututh) Nations. Further, this acknowledgement, gratitude, and respect extends to all of the First Nations communities on whose territories the Research Institute builds relationships and operates in British Columbia.
© 2026 BC Children’s Hospital Research Institute. All rights reserved.
Crafted with by Forge and Smith
